Mercer Global Advisors »

Silverback Therapeutics shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $58k 7.2k 8.01

More positions owned by Mercer Global Advisors

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Us High Prof Etf (DUHP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Msci Intl Moment (IMTM)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl High Profit (DIHP)
American Centy Etf Tr Avan Us Smal Etf (AVSC)
Ishares Tr National Mun Etf (MUB)

View all positions for Mercer Global Advisors

Top funds holding Silverback Therapeutics

RA Capital Management
Rubric Capital Management
OrbiMed Advisors
Deerfield Management Company
BlackRock
Tyro Capital Management
Standard Life Aberdeen
Sr One Capital Management
Vanguard Capital Management
Millennium Management
Janney Montgomery Scott
UBS Group
Geode Capital Management
Boothbay Fund Management
Eugene S. Stark

View all funds holding Silverback Therapeutics